236 related articles for article (PubMed ID: 33494858)
21. Pathophysiology of locus ceruleus neurons in a mouse model of Rett syndrome.
Taneja P; Ogier M; Brooks-Harris G; Schmid DA; Katz DM; Nelson SB
J Neurosci; 2009 Sep; 29(39):12187-95. PubMed ID: 19793977
[TBL] [Abstract][Full Text] [Related]
22. Morphological and functional reversal of phenotypes in a mouse model of Rett syndrome.
Robinson L; Guy J; McKay L; Brockett E; Spike RC; Selfridge J; De Sousa D; Merusi C; Riedel G; Bird A; Cobb SR
Brain; 2012 Sep; 135(Pt 9):2699-710. PubMed ID: 22525157
[TBL] [Abstract][Full Text] [Related]
23. Histone H3 and H4 modification profiles in a Rett syndrome mouse model.
Urdinguio RG; Pino I; Ropero S; Fraga MF; Esteller M
Epigenetics; 2007; 2(1):11-4. PubMed ID: 17965622
[TBL] [Abstract][Full Text] [Related]
24. The disease progression of Mecp2 mutant mice is affected by the level of BDNF expression.
Chang Q; Khare G; Dani V; Nelson S; Jaenisch R
Neuron; 2006 Feb; 49(3):341-8. PubMed ID: 16446138
[TBL] [Abstract][Full Text] [Related]
25. Mecp2 deficiency is associated with learning and cognitive deficits and altered gene activity in the hippocampal region of mice.
Pelka GJ; Watson CM; Radziewic T; Hayward M; Lahooti H; Christodoulou J; Tam PP
Brain; 2006 Apr; 129(Pt 4):887-98. PubMed ID: 16467389
[TBL] [Abstract][Full Text] [Related]
26. Cell-specific expression of wild-type MeCP2 in mouse models of Rett syndrome yields insight about pathogenesis.
Alvarez-Saavedra M; Sáez MA; Kang D; Zoghbi HY; Young JI
Hum Mol Genet; 2007 Oct; 16(19):2315-25. PubMed ID: 17635839
[TBL] [Abstract][Full Text] [Related]
27. MeCP2 dysfunction in Rett syndrome and related disorders.
Moretti P; Zoghbi HY
Curr Opin Genet Dev; 2006 Jun; 16(3):276-81. PubMed ID: 16647848
[TBL] [Abstract][Full Text] [Related]
28. Targeted delivery of an Mecp2 transgene to forebrain neurons improves the behavior of female Mecp2-deficient mice.
Jugloff DG; Vandamme K; Logan R; Visanji NP; Brotchie JM; Eubanks JH
Hum Mol Genet; 2008 May; 17(10):1386-96. PubMed ID: 18223199
[TBL] [Abstract][Full Text] [Related]
29. Rett-causing mutations reveal two domains critical for MeCP2 function and for toxicity in MECP2 duplication syndrome mice.
Heckman LD; Chahrour MH; Zoghbi HY
Elife; 2014 Jun; 3():. PubMed ID: 24970834
[TBL] [Abstract][Full Text] [Related]
30. MeCP2-mediated transcription repression in the basolateral amygdala may underlie heightened anxiety in a mouse model of Rett syndrome.
Adachi M; Autry AE; Covington HE; Monteggia LM
J Neurosci; 2009 Apr; 29(13):4218-27. PubMed ID: 19339616
[TBL] [Abstract][Full Text] [Related]
31. Tsix-Mecp2 female mouse model for Rett syndrome reveals that low-level MECP2 expression extends life and improves neuromotor function.
Carrette LLG; Blum R; Ma W; Kelleher RJ; Lee JT
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8185-8190. PubMed ID: 30038001
[TBL] [Abstract][Full Text] [Related]
32. Pathogenesis of lethal cardiac arrhythmias in Mecp2 mutant mice: implication for therapy in Rett syndrome.
McCauley MD; Wang T; Mike E; Herrera J; Beavers DL; Huang TW; Ward CS; Skinner S; Percy AK; Glaze DG; Wehrens XH; Neul JL
Sci Transl Med; 2011 Dec; 3(113):113ra125. PubMed ID: 22174313
[TBL] [Abstract][Full Text] [Related]
33. Ocular MECP2 protein expression in patients with and without Rett syndrome.
Jain D; Singh K; Chirumamilla S; Bibat GM; Blue ME; Naidu SR; Eberhart CG
Pediatr Neurol; 2010 Jul; 43(1):35-40. PubMed ID: 20682201
[TBL] [Abstract][Full Text] [Related]
34. A mouse model for MeCP2 duplication syndrome: MeCP2 overexpression impairs learning and memory and synaptic transmission.
Na ES; Nelson ED; Adachi M; Autry AE; Mahgoub MA; Kavalali ET; Monteggia LM
J Neurosci; 2012 Feb; 32(9):3109-17. PubMed ID: 22378884
[TBL] [Abstract][Full Text] [Related]
35. Effects of postnatal dietary choline supplementation on motor regional brain volume and growth factor expression in a mouse model of Rett syndrome.
Nag N; Mellott TJ; Berger-Sweeney JE
Brain Res; 2008 Oct; 1237():101-9. PubMed ID: 18778693
[TBL] [Abstract][Full Text] [Related]
36. Environmental enrichment alters locomotor behaviour and ventricular volume in Mecp2 1lox mice.
Nag N; Moriuchi JM; Peitzman CG; Ward BC; Kolodny NH; Berger-Sweeney JE
Behav Brain Res; 2009 Jan; 196(1):44-8. PubMed ID: 18687363
[TBL] [Abstract][Full Text] [Related]
37. Brain lipid analysis in mice with Rett syndrome.
Seyfried TN; Heinecke KA; Mantis JG; Denny CA
Neurochem Res; 2009 Jun; 34(6):1057-65. PubMed ID: 19002580
[TBL] [Abstract][Full Text] [Related]
38. Astrocyte Transcriptome from the Mecp2(308)-Truncated Mouse Model of Rett Syndrome.
Delépine C; Nectoux J; Letourneur F; Baud V; Chelly J; Billuart P; Bienvenu T
Neuromolecular Med; 2015 Dec; 17(4):353-63. PubMed ID: 26208914
[TBL] [Abstract][Full Text] [Related]
39. Mecp2-null mice provide new neuronal targets for Rett syndrome.
Urdinguio RG; Lopez-Serra L; Lopez-Nieva P; Alaminos M; Diaz-Uriarte R; Fernandez AF; Esteller M
PLoS One; 2008; 3(11):e3669. PubMed ID: 18989361
[TBL] [Abstract][Full Text] [Related]
40. Disrupted microRNA expression caused by Mecp2 loss in a mouse model of Rett syndrome.
Urdinguio RG; Fernandez AF; Lopez-Nieva P; Rossi S; Huertas D; Kulis M; Liu CG; Croce CM; Calin GA; Esteller M
Epigenetics; 2010 Oct; 5(7):656-63. PubMed ID: 20716963
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
